Lasa Supergenerics' Stock Soars, Outperforming Sector and Sensex

Jan 05 2024 08:13 PM IST
share
Share Via
Lasa Supergenerics, a microcap pharmaceutical company listed on the Indian stock exchange, has shown a significant improvement in its stock performance. It has outperformed the sector by 9.52% and is currently trading higher than its moving averages. Despite a 'Sell' call from MarketsMojo, investors should do their own research on this promising company.


Lasa Supergenerics, a microcap pharmaceutical company, has been making headlines in the stock market recently. The company's stock, which is listed on the Indian stock exchange, has been on a rollercoaster ride, with its price reaching a high of Rs.35.91 and a low of Rs.33.51.

Today, the stock has been performing well, outperforming the sector by 9.52%. It opened with a gain of 5.57% and touched an intraday high of Rs.35.91, which is a 9.98% increase. This is a significant improvement from its previous performance, as the stock has been gaining for the last four days and has risen by 25.17% in that period.

Moreover, Lasa Supergenerics is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which is a positive sign for investors.

In comparison to the overall market performance, Lasa Supergenerics has outperformed the Sensex by a significant margin. While the stock has shown a 9.37% increase in just one day, the Sensex has only seen a 0.25% increase.

Despite the positive performance of Lasa Supergenerics, MarketsMOJO has given a 'Sell' call for the stock. This could be due to various factors, such as the company's size being a microcap and the current market conditions. However, it is important to note that this is not a recommendation from experts or based on future potential, but rather a fact-based analysis of the stock's performance.

Investors should do their own research and make informed decisions before investing in Lasa Supergenerics. With its recent performance and positive indicators, the company is definitely one to watch in the pharmaceutical industry.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News